These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9610676)

  • 1. Opiates as potential cofactors in progression of HIV-1 infections to AIDS.
    Donahoe RM; Vlahov D
    J Neuroimmunol; 1998 Mar; 83(1-2):77-87. PubMed ID: 9610676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model.
    Donahoe RM
    J Neuroimmunol; 2004 Feb; 147(1-2):28-32. PubMed ID: 14741423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque/SIVsmm9 model.
    Donahoe RM; O'neil SP; Marsteller FA; Novembre FJ; Anderson DC; Lankford-Turner P; McClure HH
    J Acquir Immune Defic Syndr; 2009 Mar; 50(3):241-9. PubMed ID: 19194320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS.
    Donahoe RM; Falek A
    Adv Biochem Psychopharmacol; 1988; 44():145-58. PubMed ID: 3041744
    [No Abstract]   [Full Text] [Related]  

  • 5. Opioids and HIV/HCV infection.
    Wang X; Zhang T; Ho WZ
    J Neuroimmune Pharmacol; 2011 Dec; 6(4):477-89. PubMed ID: 21755286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of Opiate Abuse on Expression of Toll-like Receptor 9 in Peripheral Blood Mononuclear Cells of HIV-1-Infected Individuals].
    Pan P; Wei F; Jiang J; Liang B; Huang J; Liao Y; Su J; Li Y; Yang X; Chen H; Ye L; Liang H
    Bing Du Xue Bao; 2015 Mar; 31(2):132-8. PubMed ID: 26164937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate drug use and the pathophysiology of neuroAIDS.
    Hauser KF; Fitting S; Dever SM; Podhaizer EM; Knapp PE
    Curr HIV Res; 2012 Jul; 10(5):435-52. PubMed ID: 22591368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of opiate-HIV-1 interactions on neurotoxic signaling.
    Hauser KF; El-Hage N; Buch S; Nath A; Tyor WR; Bruce-Keller AJ; Knapp PE
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):98-105. PubMed ID: 18040795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate effects on in vitro human retroviral infection.
    Nyland SB; Specter S; Im-Sin J; Ugen KE
    Adv Exp Med Biol; 1998; 437():91-100. PubMed ID: 9666261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs of abuse, immune modulation, and AIDS.
    Cabral GA
    J Neuroimmune Pharmacol; 2006 Sep; 1(3):280-95. PubMed ID: 18040805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism.
    Festa L; Meucci O
    Curr HIV Res; 2012 Jul; 10(5):453-62. PubMed ID: 22591369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity.
    Mahajan SD; Aalinkeel R; Parikh NU; Jacob A; Cwiklinski K; Sandhu P; Le K; Loftus AW; Schwartz SA; Quigg RJ; Alexander JJ
    Immunol Invest; 2017 Nov; 46(8):816-832. PubMed ID: 29058550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of opiate-dependency in a monkey model of AIDS.
    Donahoe RM; Byrd LD; McClure HM; Fultz P; Brantley M; Marsteller F; Ansari AA; Wenzel D; Aceto M
    Adv Exp Med Biol; 1993; 335():21-8. PubMed ID: 8237597
    [No Abstract]   [Full Text] [Related]  

  • 14. Cocaine abuse and HIV-1 infection: epidemiology and neuropathogenesis.
    Goodkin K; Shapshak P; Metsch LR; McCoy CB; Crandall KA; Kumar M; Fujimura RK; McCoy V; Zhang BT; Reyblat S; Xin KQ; Kumar AM
    J Neuroimmunol; 1998 Mar; 83(1-2):88-101. PubMed ID: 9610677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiates and immune function. Consequences on infectious diseases with special reference to AIDS.
    Rouveix B
    Therapie; 1992 Nov; 47(6):503-12. PubMed ID: 1301643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology of human immunodeficiency virus infection at different disease stages.
    Kibayashi K; Mastri AR; Hirsch CS
    Hum Pathol; 1996 Jul; 27(7):637-42. PubMed ID: 8698305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
    Hazenberg MD; Otto SA; van Benthem BH; Roos MT; Coutinho RA; Lange JM; Hamann D; Prins M; Miedema F
    AIDS; 2003 Sep; 17(13):1881-8. PubMed ID: 12960820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate abuse, innate immunity, and bacterial infectious diseases.
    Wang J; Barke RA; Ma J; Charboneau R; Roy S
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):299-309. PubMed ID: 18836861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine complications of AIDS and drug addiction.
    Brown LS; Singer F; Killian P
    Endocrinol Metab Clin North Am; 1991 Sep; 20(3):655-73. PubMed ID: 1935923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.